Anebulo Pharmaceuticals (ANEB) Enterprise Value (2021 - 2025)
Anebulo Pharmaceuticals (ANEB) reported Enterprise Value of $32.45 million for fiscal Q2 2026 (quarter ended Dec 31, 2025), up 4.5% from $31.06 million a year earlier but down 64.9% from the prior quarter.
Anebulo Pharmaceuticals (ANEB) Enterprise Value (2021 - 2025) Analysis & Trends
Over the twelve months ended Dec 31, 2025, Anebulo Pharmaceuticals' Enterprise Value came in at -$2.81 million; for FY2025 (ended Jun 30, 2025), it came in at $37.07 million, down 45.2% from FY2024.
- Enterprise Value has a four-year compound annual growth rate of -15.5% (FY2021 to FY2025).
- By fiscal year, Enterprise Value came in at $67.7 million in FY2024 (+38.2%), $48.99 million in FY2023 (-54.1%), $106.84 million in FY2022 (+46.7%) and $72.85 million in FY2021.
- Five-year quarterly Enterprise Value spans a low of $31.06 million in fiscal Q2 2025 and a high of $148.73 million in fiscal Q3 2022.
- Year over year, Enterprise Value gained in four of the last eight quarters, with an average decline of 1.8%.
- The high point for year-over-year Enterprise Value in five years was fiscal Q1 2026 (growth of 89.9%); the low point was fiscal Q2 2023 (a decline of 63.6%).
- Per Business Quant data, the three fiscal quarters before Q2 2026 came in at $92.36 million (Q1 2026), $37.07 million (Q4 2025) and $40.13 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Anebulo Pharmaceuticals | 13.15 Mn | 13.15 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 32.45 Mn |
| Sep 30, 2025 | 92.36 Mn |
| Jun 30, 2025 | 37.07 Mn |
| Mar 31, 2025 | 40.13 Mn |
| Dec 31, 2024 | 31.06 Mn |
| Sep 30, 2024 | 48.65 Mn |
| Jun 30, 2024 | 67.70 Mn |
| Mar 31, 2024 | 69.28 Mn |
| Dec 31, 2023 | 56.11 Mn |
| Sep 30, 2023 | 69.92 Mn |
| Jun 30, 2023 | 48.99 Mn |
| Mar 31, 2023 | 60.17 Mn |
| Dec 31, 2022 | 45.68 Mn |
| Sep 30, 2022 | 52.56 Mn |
| Jun 30, 2022 | 106.84 Mn |
| Mar 31, 2022 | 148.73 Mn |
| Dec 31, 2021 | 125.56 Mn |
| Sep 30, 2021 | 133.70 Mn |
| Jun 30, 2021 | 72.85 Mn |
Anebulo Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ANEB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();